Case Study, Drug Development and healthcare technology

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Case Study

Drug Development

healthcare technology

How can Palantir win 'hearts and minds' to deliver the NHS England Federated Data Platform?

Lloyd Price

NOVEMBER 21, 2023

Real-world examples and case studies can showcase the platform's impact. Emphasize Local Partnerships: Partner with local companies and organizations to demonstrate Palantir's commitment to the UK healthcare ecosystem. The company is well-positioned to continue to be successful in healthcare in the future.

Drug Development

Drug Development Health science healthcare technology Leadership

Sovereign Health Fund: time to unlock the potential £5Bn ARR asset based on unique NHS datasets?

Lloyd Price

AUGUST 9, 2023

Exec Summary: The concept of a UK sovereign health fund based on NHS data is still in its early stages of development, but it has the potential to revolutionize the way healthcare is funded and delivered in the UK. Overall, the concept of a UK sovereign health fund based on NHS data is still in its early stages of development.

healthcare technology

healthcare technology Healthcare Innovation Drug Development Health Data

Connected Health Pulse

How can Palantir win 'hearts and minds' to deliver the NHS England Federated Data Platform?

Sovereign Health Fund: time to unlock the potential £5Bn ARR asset based on unique NHS datasets?

Stay Connected